Doxepin 25mg Capsules

Manufacturer AMNEAL Active Ingredient Doxepin Capsules(DOKS e pin) Pronunciation DOKS e pin
WARNING: Drugs like this one have raised the chance of suicidal thoughts or actions in children and young adults. The risk may be greater in people who have had these thoughts or actions in the past. All people who take this drug need to be watched closely. Call the doctor right away if signs like depression, nervousness, restlessness, grouchiness, panic attacks, or changes in mood or actions are new or worse. Call the doctor right away if any thoughts or actions of suicide occur.This drug is not approved for use in children. Talk with the doctor. @ COMMON USES: It is used to treat depression.It is used to treat anxiety.It may be given to you for other reasons. Talk with the doctor.
đŸˇī¸
Drug Class
Antidepressant; Anxiolytic; Hypnotic; Antipruritic
đŸ§Ŧ
Pharmacologic Class
Tricyclic Antidepressant (TCA); Histamine H1 Antagonist
🤰
Pregnancy Category
Category C
✅
FDA Approved
Jun 1969
âš–ī¸
DEA Schedule
Not Controlled

Overview

â„šī¸

What is this medicine?

Doxepin is a medication that belongs to a class of drugs called tricyclic antidepressants (TCAs). It works by affecting certain natural chemicals in the brain that help regulate mood and sleep. It is used to treat depression, anxiety, and sometimes for insomnia (trouble sleeping) or severe itching.
📋

How to Use This Medicine

Taking Your Medication

To use this medication correctly, follow your doctor's instructions and read all the information provided. Take your medication as directed, and if you're taking it once a day, take it at bedtime. Continue taking this medication as prescribed by your doctor or healthcare provider, even if you're feeling well.

Storing and Disposing of Your Medication

Store your medication at room temperature, protected from light, and in a dry place. Avoid storing it in a bathroom. Keep all medications in a safe location, out of the reach of children and pets. When disposing of unused or expired medications, do not flush them down the toilet or pour them down the drain unless instructed to do so. Instead, check with your pharmacist for guidance on the best disposal method. You may also want to inquire about drug take-back programs in your area.

Missing a Dose

If you miss a dose, take it as soon as you remember. However, if it's close to the time for your next dose, skip the missed dose and resume your regular schedule. Do not take two doses at the same time or take extra doses to make up for a missed one.
💡

Lifestyle & Tips

  • Avoid alcohol and other CNS depressants (e.g., sleeping pills, tranquilizers) as they can increase drowsiness and other side effects.
  • Be cautious when driving or operating machinery until you know how this medication affects you, as it can cause significant drowsiness and blurred vision.
  • Avoid sudden changes in position (e.g., standing up quickly) to prevent dizziness or lightheadedness due to orthostatic hypotension.
  • Maintain good oral hygiene and use sugar-free gum or lozenges to help with dry mouth.
  • Increase fiber and fluid intake to help prevent constipation.
  • Do not stop taking this medication suddenly without consulting your doctor, as withdrawal symptoms can occur.

Dosing & Administration

đŸ‘¨â€âš•ī¸

Adult Dosing

Standard Dose: For depression/anxiety: 75-150 mg/day, usually given at bedtime or in divided doses. For insomnia: 3-6 mg once daily at bedtime (Silenor). For pruritus: 10-75 mg/day.
Dose Range: 3 - 300 mg

Condition-Specific Dosing:

depression_anxiety: Initial: 25-50 mg/day. Therapeutic range: 75-150 mg/day. Max: 300 mg/day.
insomnia: 3-6 mg once daily at bedtime (Silenor formulation).
pruritus: 10-75 mg/day, usually given at bedtime.
đŸ‘ļ

Pediatric Dosing

Neonatal: Not established
Infant: Not established
Child: Not established for depression/anxiety due to suicidality risk. Use for other conditions (e.g., pruritus) is off-label and requires careful consideration.
Adolescent: Not established for depression/anxiety due to suicidality risk. If used, initiate at low doses and titrate slowly with close monitoring.
âš•ī¸

Dose Adjustments

Renal Impairment:

Mild: No specific dose adjustment generally required, but monitor for increased side effects.
Moderate: No specific dose adjustment generally required, but monitor for increased side effects.
Severe: Use with caution. Consider lower doses and extended dosing intervals due to potential for accumulation of parent drug and active metabolites.
Dialysis: Doxepin is highly protein bound and has a large volume of distribution, making it unlikely to be significantly removed by dialysis. Use with caution and monitor for adverse effects.

Hepatic Impairment:

Mild: Use with caution. Consider lower doses.
Moderate: Use with caution. Significant dose reduction (e.g., 50%) may be necessary. Monitor plasma levels if available.
Severe: Contraindicated or use with extreme caution and significant dose reduction. Doxepin is extensively metabolized by the liver.

Pharmacology

đŸ”Ŧ

Mechanism of Action

Doxepin is a tricyclic antidepressant (TCA) that primarily inhibits the reuptake of norepinephrine (NE) and serotonin (5-HT) at the presynaptic neuronal membrane, thereby increasing the concentration of these neurotransmitters in the synaptic cleft. It also possesses potent antihistaminic (H1), anticholinergic (muscarinic), and alpha-1 adrenergic blocking properties, which contribute to its sedative and adverse effects.
📊

Pharmacokinetics

Absorption:

Bioavailability: Variable (due to significant first-pass metabolism)
Tmax: 2-4 hours (for parent drug); 6-10 hours (for active metabolite, desmethyldoxepin)
FoodEffect: Food may delay absorption but does not significantly affect the extent of absorption.

Distribution:

Vd: 20-40 L/kg (large volume of distribution)
ProteinBinding: >90%
CnssPenetration: Yes

Elimination:

HalfLife: Doxepin: 10-25 hours; Desmethyldoxepin: 28-51 hours
Clearance: Not readily available, but extensive hepatic metabolism
ExcretionRoute: Renal (primarily as metabolites)
Unchanged: <5%
âąī¸

Pharmacodynamics

OnsetOfAction: Sedative/hypnotic effects: within 30-60 minutes. Antidepressant/anxiolytic effects: 2-4 weeks.
PeakEffect: Sedative/hypnotic effects: 1-3 hours. Antidepressant/anxiolytic effects: 4-6 weeks.
DurationOfAction: Sedative/hypnotic effects: 6-8 hours (low dose). Antidepressant/anxiolytic effects: 24 hours (due to long half-life of parent drug and active metabolite).

Safety & Warnings

âš ī¸

BLACK BOX WARNING

Antidepressants increased the risk compared to placebo of suicidal thinking and behavior (suicidality) in children, adolescents, and young adults in short-term studies of Major Depressive Disorder (MDD) and other psychiatric disorders. Anyone considering the use of Doxepin or any other antidepressant in a child, adolescent, or young adult must balance this risk with the clinical need. Short-term studies did not show an increase in the risk of suicidality with antidepressants compared to placebo in adults beyond age 24; there was a reduction in risk with antidepressants compared to placebo in adults aged 65 and older. Depression and certain other psychiatric disorders are themselves associated with increases in the risk of suicide. Patients of all ages who are started on antidepressant therapy should be monitored appropriately and observed closely for clinical worsening, suicidality, or unusual changes in behavior. Families and caregivers should be advised of the need for close observation and communication with the prescriber.
âš ī¸

Side Effects

Urgent Side Effects: Seek Medical Help Right Away

Although rare, some people may experience severe and potentially life-threatening side effects while taking this medication. If you notice any of the following symptoms, contact your doctor or seek immediate medical attention:

Signs of an allergic reaction, such as:
+ Rash
+ Hives
+ Itching
+ Red, swollen, blistered, or peeling skin with or without fever
+ Wheezing
+ Tightness in the chest or throat
+ Trouble breathing, swallowing, or talking
+ Unusual hoarseness
+ Swelling of the mouth, face, lips, tongue, or throat
Signs of high or low blood pressure, including:
+ Severe headache or dizziness
+ Passing out
+ Changes in eyesight
Fast heartbeat
Difficulty urinating
Feeling extremely nervous or excitable
Fever, chills, or sore throat
Unexplained bruising or bleeding
Feeling very tired or weak
Yellowing of the skin or eyes (jaundice)
Ringing in the ears (tinnitus)
Changes in sex drive
Enlarged breasts or nipple discharge
Swelling of the testicles

Important Warning for Asthma Patients

If you have asthma, use this medication with caution. Worsening of asthma symptoms has been reported in people taking this medication. If your asthma symptoms worsen while taking this medication, contact your doctor immediately.

Other Possible Side Effects

Like all medications, this drug can cause side effects. Many people may not experience any side effects or may only have mild symptoms. However, if you notice any of the following side effects or if they bother you or do not go away, contact your doctor or seek medical help:

Feeling dizzy, sleepy, tired, or weak
Constipation, diarrhea, stomach pain, upset stomach, vomiting, or decreased appetite
Dry mouth
Changes in taste
Mouth irritation or mouth sores
Weight gain
Excessive sweating
Flushing
Hair loss
* Headache

Reporting Side Effects

This is not an exhaustive list of possible side effects. If you have questions or concerns about side effects, contact your doctor. You can also report side effects to the FDA at 1-800-332-1088 or online at https://www.fda.gov/medwatch.
🚨

Seek Immediate Medical Attention If You Experience:

  • Worsening depression or thoughts about harming yourself (especially in the first few weeks of treatment or after a dose change)
  • New or worsening anxiety, agitation, panic attacks, irritability, hostility, aggressiveness, impulsivity, or restlessness
  • Extreme increase in activity and talking (mania)
  • Severe dizziness or fainting
  • Fast or irregular heartbeat
  • Difficulty urinating
  • Severe constipation
  • Blurred vision or eye pain
  • Seizures
  • Yellowing of the skin or eyes (jaundice)
📋

Before Using This Medicine

Before Taking This Medication: Important Information to Share with Your Doctor

It is essential to inform your doctor about the following:

Any allergies you have, including allergies to this medication, its components, or other substances. Be sure to describe the allergic reaction you experienced.
Certain health conditions, such as:
+ Difficulty urinating
+ Glaucoma
Current or recent use of specific medications, including:
+ Linezolid or methylene blue
+ Certain antidepressants or Parkinson's disease medications taken within the last 14 days, including isocarboxazid, phenelzine, tranylcypromine, selegiline, or rasagiline (as this may lead to very high blood pressure)
Use of other medications that can cause drowsiness, as there are many drugs with this potential effect. If you are unsure, consult your doctor or pharmacist.
* If you are breastfeeding, as you should not breastfeed while taking this medication.

This list is not exhaustive, and it is crucial to discuss all your medications (prescription, over-the-counter, natural products, and vitamins) and health problems with your doctor and pharmacist. They will help determine if it is safe to take this medication with your other medications and health conditions. Never start, stop, or change the dose of any medication without first consulting your doctor.
âš ī¸

Precautions & Cautions

It is essential to inform all your healthcare providers, including doctors, nurses, pharmacists, and dentists, that you are taking this medication. This will help ensure your safety and prevent any potential interactions with other treatments.

Until you know how this medication affects you, avoid driving and engaging in activities that require you to be alert. You may not experience the full effects of the medication for several weeks.

Do not stop taking this medication abruptly without consulting your doctor, as this may increase your risk of side effects. If you need to discontinue the medication, your doctor will instruct you on how to gradually taper off the dosage to minimize potential risks.

While taking this medication, it is recommended that you avoid consuming alcohol. Additionally, consult your doctor before using marijuana, cannabis products, or prescription or over-the-counter medications that may cause drowsiness or impair your reactions.

Some individuals may be at a higher risk of developing eye problems while taking this medication. Your doctor may recommend an eye exam to assess your risk. If you experience eye pain, changes in vision, or swelling and redness in or around the eye, contact your doctor immediately.

This medication may increase your sensitivity to the sun, making you more prone to sunburn. Take necessary precautions when spending time outdoors, and inform your doctor if you experience excessive sunburning while taking this medication.

If you have diabetes, it is crucial to closely monitor your blood sugar levels. Be aware of the signs of high or low blood sugar, which may include fruity breath odor, dizziness, rapid breathing, rapid heartbeat, confusion, drowsiness, weakness, flushing, headache, unusual thirst or hunger, frequent urination, shaking, or sweating. Report any of these symptoms to your doctor.

If you are 65 years or older, use this medication with caution, as you may be more susceptible to side effects.

Some medications, including this one, may affect fertility and the ability to conceive. If you have concerns or questions, discuss them with your doctor.

If you are pregnant or planning to become pregnant, consult your doctor to weigh the benefits and risks of taking this medication during pregnancy. Taking this medication in the third trimester may pose health risks to the newborn, so it is essential to discuss this with your doctor.
🆘

Overdose Information

Overdose Symptoms:

  • Severe drowsiness or coma
  • Confusion or agitation
  • Hallucinations
  • Severe dry mouth
  • Blurred vision
  • Dilated pupils
  • Fast, irregular, or pounding heartbeat (tachycardia, arrhythmias)
  • Low blood pressure (hypotension)
  • Urinary retention
  • Seizures
  • Respiratory depression
  • Hypothermia

What to Do:

Seek immediate medical attention. Call 911 or your local emergency number. For poison control, call 1-800-222-1222.

Drug Interactions

đŸšĢ

Contraindicated Interactions

  • Monoamine Oxidase Inhibitors (MAOIs) - risk of hyperpyretic crisis, severe convulsions, and death.
  • Linezolid (reversible MAOI)
  • Methylene Blue (reversible MAOI)
🔴

Major Interactions

  • CNS Depressants (e.g., alcohol, benzodiazepines, opioids, sedatives, hypnotics) - additive CNS depression.
  • Anticholinergic Agents (e.g., atropine, scopolamine, antihistamines, antipsychotics) - additive anticholinergic effects (e.g., severe constipation, urinary retention, blurred vision, delirium).
  • Sympathomimetics (e.g., epinephrine, norepinephrine, phenylephrine) - potentiation of cardiovascular effects.
  • QT-prolonging drugs (e.g., antiarrhythmics, certain antipsychotics, fluoroquinolones) - increased risk of QT prolongation and arrhythmias.
  • CYP2D6 Inhibitors (e.g., quinidine, fluoxetine, paroxetine, bupropion) - increased plasma concentrations of doxepin and desmethyldoxepin.
  • Thyroid hormones - increased risk of cardiac arrhythmias.
🟡

Moderate Interactions

  • Cimetidine - inhibits doxepin metabolism, increasing plasma levels.
  • Oral anticoagulants (e.g., warfarin) - potential for increased anticoagulant effect.
  • Antihypertensives (e.g., guanethidine, clonidine) - doxepin may antagonize their hypotensive effects.
  • Adrenergic neuron blockers (e.g., reserpine) - may reduce antidepressant effect.
đŸŸĸ

Minor Interactions

  • Tobacco smoking - may induce CYP1A2, potentially decreasing doxepin levels.

Monitoring

đŸ”Ŧ

Baseline Monitoring

Complete Medical History and Physical Exam

Rationale: To identify pre-existing conditions (e.g., cardiac disease, glaucoma, urinary retention, seizure disorder) that may contraindicate or require caution with doxepin use.

Timing: Prior to initiation

Electrocardiogram (ECG)

Rationale: To assess for pre-existing cardiac conduction abnormalities, especially in patients with cardiac disease or at higher doses, due to potential for QT prolongation and other arrhythmias.

Timing: Prior to initiation (especially in elderly or those with cardiac risk factors)

Liver Function Tests (LFTs)

Rationale: To assess hepatic function, as doxepin is extensively metabolized by the liver. Impaired hepatic function may necessitate dose adjustment.

Timing: Prior to initiation

Renal Function Tests (e.g., BUN, Creatinine)

Rationale: To assess renal function, as metabolites are renally excreted. Impaired renal function may necessitate dose adjustment.

Timing: Prior to initiation

Mental Status Examination (including suicidality assessment)

Rationale: To establish baseline mood, anxiety, and suicidal ideation, especially in young adults and adolescents.

Timing: Prior to initiation

📊

Routine Monitoring

Mental Status Examination (including suicidality assessment)

Frequency: Weekly for first 4 weeks, then every 2 weeks for next 4 weeks, then monthly for 4 months, then periodically as clinically indicated.

Target: Improvement in target symptoms (e.g., mood, anxiety, sleep) without emergence or worsening of suicidal ideation or agitation.

Action Threshold: Worsening depression, emergence of suicidal ideation, unusual changes in behavior (e.g., agitation, hostility, impulsivity, mania) require immediate re-evaluation and potential dose adjustment or discontinuation.

Vital Signs (Blood Pressure, Heart Rate)

Frequency: Periodically, especially during dose titration.

Target: Within normal limits for the patient.

Action Threshold: Significant orthostatic hypotension, persistent tachycardia, or other arrhythmias require investigation and potential dose adjustment or discontinuation.

Adverse Effects Monitoring (e.g., anticholinergic effects, sedation)

Frequency: Regularly, especially during dose titration.

Target: Tolerable level of side effects.

Action Threshold: Severe dry mouth, blurred vision, urinary retention, constipation, excessive sedation, or cognitive impairment may require dose reduction or alternative therapy.

Plasma Doxepin/Desmethyldoxepin Levels (Therapeutic Drug Monitoring)

Frequency: Not routinely recommended, but may be useful in cases of non-response, suspected toxicity, or significant drug interactions.

Target: Combined plasma levels of doxepin and desmethyldoxepin for depression/anxiety: 100-250 ng/mL.

Action Threshold: Levels outside therapeutic range may indicate need for dose adjustment or investigation of adherence/metabolism.

đŸ‘ī¸

Symptom Monitoring

  • Worsening depression
  • Suicidal ideation or behavior
  • Unusual changes in behavior (e.g., agitation, irritability, hostility, impulsivity, akathisia, hypomania, mania)
  • Sedation or somnolence
  • Dry mouth
  • Blurred vision
  • Urinary retention
  • Constipation
  • Dizziness or orthostatic hypotension
  • Tachycardia or palpitations
  • Confusion or delirium (especially in elderly)
  • Seizures

Special Patient Groups

🤰

Pregnancy

Category C. Use during pregnancy only if the potential benefit justifies the potential risk to the fetus. Doxepin crosses the placenta. Neonatal withdrawal symptoms (e.g., respiratory distress, cyanosis, apnea, seizures, feeding difficulties, hypotonia, hypertonia, tremor, irritability, persistent crying) have been reported in neonates exposed to TCAs during the third trimester.

Trimester-Specific Risks:

First Trimester: Limited human data, but animal studies show some adverse effects. Risk of congenital malformations is generally considered low, but caution is advised.
Second Trimester: Risk of neonatal withdrawal symptoms increases with exposure closer to term.
Third Trimester: Increased risk of neonatal withdrawal symptoms and potential for cardiac effects in the neonate.
🤱

Lactation

Doxepin and its active metabolite are excreted into breast milk. The American Academy of Pediatrics considers TCAs to be compatible with breastfeeding, but caution is advised. Monitor the infant for sedation, poor feeding, and weight gain.

Infant Risk: Low to moderate. Potential for sedation, irritability, and poor feeding in the infant. Consider alternative agents or monitor infant closely.
đŸ‘ļ

Pediatric Use

Not approved for depression or anxiety in pediatric patients due to the Black Box Warning regarding increased risk of suicidality. Use for other conditions (e.g., pruritus) is off-label and should be done with extreme caution and close monitoring.

👴

Geriatric Use

Elderly patients are more sensitive to the anticholinergic, sedative, and hypotensive effects of doxepin. Start with lower doses (e.g., 10-25 mg/day) and titrate slowly. Increased risk of falls, cognitive impairment, and cardiac arrhythmias. Avoid in patients with dementia-related psychosis.

Clinical Information

💎

Clinical Pearls

  • Doxepin is a potent H1 antagonist, making it highly sedating. This property is leveraged for its use in insomnia at very low doses (3-6 mg).
  • Due to its anticholinergic properties, doxepin should be used with extreme caution or avoided in patients with narrow-angle glaucoma, urinary retention, or prostatic hypertrophy.
  • The full antidepressant effect may take 2-4 weeks to manifest, but sedative effects are immediate.
  • Orthostatic hypotension is a common side effect, especially at initiation and with dose increases. Advise patients to rise slowly.
  • Plasma levels of doxepin and its active metabolite, desmethyldoxepin, can be measured, but therapeutic drug monitoring is not routinely required unless there is concern for toxicity, non-response, or drug interactions.
  • Overdose can be life-threatening due to cardiac arrhythmias, severe hypotension, and CNS depression. Management is supportive.
  • Consider ECG monitoring in elderly patients or those with pre-existing cardiac disease, especially at higher doses.
🔄

Alternative Therapies

  • For depression/anxiety: SSRIs (e.g., fluoxetine, sertraline, escitalopram), SNRIs (e.g., venlafaxine, duloxetine), other TCAs (e.g., amitriptyline, imipramine, nortriptyline), atypical antidepressants (e.g., bupropion, mirtazapine).
  • For insomnia: Z-drugs (e.g., zolpidem, eszopiclone), benzodiazepines (e.g., temazepam), ramelteon, suvorexant, trazodone, mirtazapine.
  • For pruritus: Antihistamines (e.g., hydroxyzine, diphenhydramine), topical corticosteroids, other antipruritics.
💰

Cost & Coverage

Average Cost: Varies widely, typically $10-$50 per 30 capsules (25mg)
Generic Available: Yes
Insurance Coverage: Tier 1 or Tier 2 (Generic)
📚

General Drug Facts

If your symptoms or health issues persist or worsen, it is essential to contact your doctor promptly. To ensure safe use, never share your medication with others, and do not take medication prescribed to someone else. This medication is accompanied by a Medication Guide, which provides crucial information for patients. It is important to read this guide carefully and review it again whenever your prescription is refilled. If you have any questions or concerns about this medication, consult your doctor, pharmacist, or healthcare provider. In the event of a suspected overdose, immediately call the poison control center or seek emergency medical attention. When seeking help, be prepared to provide details about the overdose, including the substance taken, the amount, and the time it occurred.